B. Hartrodt
- Biochemistry top 2%
- Amino Acid Enzymes and Metabolism 8
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 8
- Peptidase Inhibition and Analysis 5
- Physiology top 5%
- Adenosine and Purinergic Signaling 8
-
- Neuropeptides and Animal Physiology 12
-
- Chemical Synthesis and Analysis 10
- Receptor Mechanisms and Signaling 5
-
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 4
B. Hartrodt
35 papers receiving 896 citations
Peers
Comparison fields: 5 of 81
- Biochemistry 179
- Oncology 521
- Physiology 70
- Cellular and Molecular Neuroscience 252
- Molecular Biology 475
Countries citing papers authored by B. Hartrodt
This map shows the geographic impact of B. Hartrodt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Hartrodt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Hartrodt more than expected).
Fields of papers citing papers by B. Hartrodt
This network shows the impact of papers produced by B. Hartrodt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Hartrodt. The network helps show where B. Hartrodt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside B. Hartrodt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 13 | |
| 2 | 2006 | 73 | |
| 3 | 2004 | 5 | |
| 4 | New Bradykinin Analogues Modified in Position 6 and 7 with Naphthylalanine | 2003 | 4 |
| 5 | 2003 | 47 | |
| 6 | New bradykinin Analogues Substituted in Positions 6 and 7 with Enantiomers of N-Methylphenylalanine | 2002 | 1 |
| 7 | 2002 | 35 | |
| 8 | 2002 | 39 | |
| 9 | 2001 | 10 | |
| 10 | 1999 | 57 | |
| 11 | 1994 | 27 | |
| 12 | 1991 | 1 | |
| 13 | 1991 | 120 | |
| 14 | Structure-activity studies of novel casomorphin analogues: binding profiles towards mu 1-, mu 2- and delta -opioid receptors. | 1991 | 5 |
| 15 | 1988 | 4 | |
| 16 | 1988 | 93 | |
| 17 | Metabolism of D-proline beta-casomorphin derivatives in the rat brain. | 1988 | 2 |
| 18 | 1983 | 36 | |
| 19 | [Synthesis and enzymatic degradation of beta-casomorphin-5 (author's transl)]. | 1982 | 2 |
| 20 | 1978 | 0 |
About B. Hartrodt
B. Hartrodt is a scholar working on Physiology, Biochemistry and Cellular and Molecular Neuroscience, having authored 36 papers that have together received 921 indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (12 papers), Chemical Synthesis and Analysis (10 papers), Amino Acid Enzymes and Metabolism (8 papers), Drug Transport and Resistance Mechanisms (8 papers), Adenosine and Purinergic Signaling (8 papers), Peptidase Inhibition and Analysis (5 papers), Receptor Mechanisms and Signaling (5 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). The work is most often cited by research in Biochemistry (179 citations), Oncology (521 citations) and Physiology (70 citations). B. Hartrodt has collaborated with scholars based in Germany, Hungary and Poland. Frequent co-authors include Klaus Neubert, K. Neubert, Matthias Brandsch, Ilka Knütter, Jochen Heins, Stephan Theis, Ilona Born, A. Barth, Jens‐Ulrich Rahfeld and Iris Thondorf. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.